Analysis of Neurodegenerative Process Within Visual Ways In Multiple Sclerosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

108 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-04-21

Study Completion Date

2019-01-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will interest in the pathophysiology of silent retinal axonal loss in multiple sclerosis. Recent studies have suggested that silent retinal axonal loss (no past history of optic neuritis \[ON\]) may be due to inflammatory lesions within the optic radiations and a transsynaptic degenerative process. The objective is to measure the exact role of silent optic nerve lesion in the occurrence of silent retinal axonal loss by performing OCT, brain and optic nerve MRI in a cohort of patients without recent disease activity.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Visual (Path)Ways in Multiple Sclerosis - Part II

NCT06776224

Multiple Sclerosis, Optic Neuritis, Demyelinating Disease

RECRUITING NA

Predictive Value of the Optic Nerve Involvement in Clinically Isolated Syndrome

NCT06455332

Clinically Isolated Syndrome Multiple Sclerosis

RECRUITING NA

CHRONIC OPTIC NEUROPATHY IN MULTIPLE SCLEROSIS

NCT02543788

Chronic Optic Neuropathy in Multiple Sclerosis

COMPLETED NA

Multimodal Exploration of Patients With Multiple Sclerosis for an Early Detection of Subtle Progression

NCT05941975

Multiple Sclerosis

RECRUITING NA

Visual Impairment, Oscillopsia and Multiple Sclerosis

NCT00498199

Multiple Sclerosis

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will interest in the neurodegenerative process reported in multiple sclerosis within the visual ways.

Symptomatic and asymptomatic retinal axonal loss in multiple sclerosis (MS) have largely been described. Many recent optical coherence tomography (OCT) studies have suggested that subclinical retinal axonal loss (no past history of optic neuritis \[ON\]) observed in MS mainly due to inflammatory and demyelinating lesions within the optic radiations and a retrograde transsynaptic degenerative process. None of these studies clearly tried to investigate the role of asymptomatic optic nerve lesion(s) in subclinical retinal axonal loss occurence.

The main objective of the study is to measure the exact role of silent optic nerve lesion in the occurrence of silent retinal axonal loss by performing OCT, brain and optic nerve MRI. The study will focus on a cohort of patients without recent disease activity in order to exclude or minimize the risk of recent and old lesion occurence on the visual ways, which could be a bias in our analysis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Relapsing Remitting Multiple Sclerosis (RRMS) patients treated by natalizumab for more than 6 months
* JohnCunninghamVirus (JCV) index \< 0.9
* patients followed in our MS center from the beginning of the disease